公司資料
Synaptogenix 股價、新聞與催化劑
- 股票代碼:
- SNPX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
24.55 USD (+1.20%)
收盤價
最後更新: 2026年4月20日
—
市值
股價為何變動
Current closing-price context is not available for SNPX.
公司概覽
業務概覽
Synaptogenix is a biotechnology company focused on neurodegenerative disease and synaptic biology. Its story centers on trying to translate brain-health science into therapies for difficult neurologic conditions.
所在地與產業分類
Synaptogenix is headquartered in the United States and listed on NASDAQ. It sits in small-cap neuroscience biotechnology.
商業模式特徵
The company depends on clinical and translational progress, capital efficiency, and the ability to maintain a focused neurologic thesis. Investors usually watch early data and strategic direction.
生技產業定位
Synaptogenix occupies a small neuroscience niche within biotech. It remains catalyst-sensitive because the company still needs to prove its platform in a difficult disease area.
未來催化劑
- Synaptogenix is a legacy / closeout story now, with catalysts limited to any strategic update. The market is not treating it like an active growth story.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。